These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8260129)

  • 41. Management of spasticity in adults: practical application of botulinum toxin.
    Pathak MS; Nguyen HT; Graham HK; Moore AP
    Eur J Neurol; 2006 Feb; 13 Suppl 1():42-50. PubMed ID: 16417597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin for the management of spasticity in multiple sclerosis: the Italian botulinum toxin network study.
    Moccia M; Frau J; Carotenuto A; Butera C; Coghe G; Barbero P; Frontoni M; Groppo E; Giovannelli M; Del Carro U; Inglese C; Frasson E; Castagna A; Buccafusca M; Latino P; Nascimbene C; Romano M; Liotti V; Lanfranchi S; Rapisarda L; Lori S; Esposito M; Maggi L; Petracca M; Lo Fermo S; Altavista MC; Bono F; Eleopra R; Brescia Morra V
    Neurol Sci; 2020 Oct; 41(10):2781-2792. PubMed ID: 32281038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Botulinum toxin in poststroke spasticity.
    Ozcakir S; Sivrioglu K
    Clin Med Res; 2007 Jun; 5(2):132-8. PubMed ID: 17607049
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The application of botulinum toxin type A in the treatment of spastic paraparesis].
    Sobolewski P
    Przegl Lek; 2007; 64 Suppl 2():3-7. PubMed ID: 17953270
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Botulinum toxin in the management of spasticity in children].
    Benrhouma H; Yacoubi J; Kraoua I; Klaa H; Ben Youssef-Turki I; Gouider-Khouja N
    Rev Neurol (Paris); 2014; 170(8-9):541-7. PubMed ID: 24953170
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Molecular mechanism of botlinum toxin therapy for spasticity].
    Sakamoto T
    Rinsho Shinkeigaku; 2012; 52(11):1270-1. PubMed ID: 23196586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin injection in patients with hereditary spastic paraparesis.
    Rousseaux M; Launay MJ; Kozlowski O; Daveluy W
    Eur J Neurol; 2007 Feb; 14(2):206-12. PubMed ID: 17250731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calf muscle volume estimates: implications for botulinum toxin treatment?
    Bandholm T; Sonne-Holm S; Thomsen C; Bencke J; Pedersen SA; Jensen BR
    Pediatr Neurol; 2007 Oct; 37(4):263-9. PubMed ID: 17903670
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Multiple sclerosis and botulinum toxin].
    Lamotte D; Thoumie P
    Ann Readapt Med Phys; 2003 Jul; 46(6):299-302. PubMed ID: 12928133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nabiximols and botulinum toxin injections for patients with multiple sclerosis: efficacy on spasticity and spasms in a single-centre experience.
    Sartori A; Dinoto A; Stragapede L; Mazzon G; Morelli ME; Pasquin F; Bratina A; Bosco A; Manganotti P
    Neurol Sci; 2021 Dec; 42(12):5037-5043. PubMed ID: 33742336
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Botulinum toxin A for spasticity, muscle spasms, and rigidity.
    Grazko MA; Polo KB; Jabbari B
    Neurology; 1995 Apr; 45(4):712-7. PubMed ID: 7723960
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin in post-stroke patients: stiffness modifications and clinical implications.
    Miscio G; Del Conte C; Pianca D; Colombo R; Panizza M; Schieppati M; Pisano F
    J Neurol; 2004 Feb; 251(2):189-96. PubMed ID: 14991354
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Botulin toxin for spasticity in spinal cord damage by treating the motor endplate].
    Keren O; Shinberg F; Catz A; Giladi N
    Harefuah; 2000 Feb; 138(3):204-8, 270. PubMed ID: 10883093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K; Lau KK; So KK; Tam CK; Wu YM; Cheung G; Liang KS; Yeung KM; Lam KY; Yui S; Leung C
    J Am Med Dir Assoc; 2012 Jun; 13(5):477-84. PubMed ID: 22521630
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of botulinum toxin type B for the treatment of detrusor hyperreflexia in a patient with multiple sclerosis: a case report.
    Dykstra DD; Pryor J; Goldish G
    Arch Phys Med Rehabil; 2003 Sep; 84(9):1399-400. PubMed ID: 13680581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of botulinum toxin injections in the management of muscle overactivity of the lower limb.
    Gracies JM; Singer BJ; Dunne JW
    Disabil Rehabil; 2007 Dec; 29(23):1789-805. PubMed ID: 18033604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity.
    Albany K
    Muscle Nerve Suppl; 1997; 6():S221-31. PubMed ID: 9826993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Botulinum toxin in the treatment of spasticity].
    Arriola-Arellano E; Chacón J; Alvarez-López M; Balbuena-García M; Fuentes-Pradera J; Vicente-Baz D
    Rev Neurol; 2006 Feb 16-28; 42(4):250-1. PubMed ID: 16521066
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.